PROGNOSTIC VALUE OF THE 3Q27 AND 18Q21 TRANSLOCATIONS FOR DIFFUSE LARGE B-CELL LYMPHOMA AND FOLLICULAR LYMPHOMA IN THE RITUXIMAB ERA

被引：0
|
作者：
Watanabe, R. [1 ]
Tomita, N. [1 ]
Matsumoto, C. [2 ]
Hattori, Y. [3 ]
Matsuura, S. [4 ]
Takasaki, H. [5 ]
Hashimoto, C. [6 ]
Fujita, H. [1 ]
Fujisawa, S. [7 ]
Ishigatsubo, Y. [1 ]
机构：
[1] Yokohama City Univ, Dept Internal Med & Clin Immunol, Grad Sch Med, Yokohama, Kanagawa 232, Japan
[2] Yokosuka City Hosp, Dept Hematol, Yokosuka, Kanagawa, Japan
[3] Fujisawa City Hosp, Dept Hematol, Fujisawa, Kanagawa, Japan
[4] Shizuoka Red Cross Hosp, Dept Hematol, Shizuoka, Japan
[5] Kanagawa Canc Ctr, Dept Oncol, Yokohama, Kanagawa 2410815, Japan
[6] Yamato Municipal Hosp, Dept Hematol, Yamato, Japan
[7] Yokohama City Univ, Dept Hematol, Med Ctr, Yokohama, Kanagawa 232, Japan
来源：
ANNALS OF ONCOLOGY | 2011年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：150 / 150
页数：1
相关论文
共 50 条
  • [31] Prognostic value of chromosomal translocations in small-bowel diffuse large B-cell lymphoma
    Ikegami, Koji
    Nakamura, Shotaro
    Esaki, Motohiro
    Yanai, Shunichi
    Hirahashi, Minako
    Oda, Yoshinao
    Takeshita, Morishige
    Matsumoto, Takayuki
    Kitazono, Takanari
    HISTOPATHOLOGY, 2016, 68 (02) : 199 - 209
  • [32] Prognostic factors for diffuse large B-cell lymphoma: clinical and biological factors in the rituximab era
    Liang, Xiping
    Hu, Renzhi
    Li, Qiying
    Wang, Chaoyu
    Liu, Yao
    EXPERIMENTAL HEMATOLOGY, 2023, 122 : 1 - 9
  • [33] PROPOSAL OF NEW PROGNOSTIC INDEX FOR PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA IN THE RITUXIMAB ERA
    Yoon, S.
    Yoon, D. H.
    Kim, S.
    Lee, K.
    Kang, E. H.
    Lee, S. W.
    Park, C. J.
    Park, C. S.
    Huh, J.
    Suh, C.
    HAEMATOLOGICA, 2015, 100 : 403 - 404
  • [34] Proposal of New Prognostic Index for Patients with Diffuse Large B-Cell Lymphoma in the Rituximab Era
    Yoon, Shinkyo
    Yoon, Dok Hyun
    Kim, Shin
    Lee, Kyoungmin
    Kang, Eun Hee
    Lee, Sang-wook
    Park, Chan-Jeoung
    Park, Chan-Sik
    Huh, Jooryung
    Suh, Cheolwon
    BLOOD, 2014, 124 (21)
  • [35] Follicular lymphoma grade IIIB includes three cytogenetically defined subgroups with primary t(14;18), 3q27 or other translocations; t(14;18) and 3q27 are mutually exclusive.
    Bosga-Bouwer, AG
    van Imhoff, GW
    Boonstra, R
    van der Veen, AY
    van den Berg, A
    de Jong, B
    Krause, V
    Palmer, MC
    van den Berg, E
    Poppema, S
    BLOOD, 2001, 98 (11) : 723A - 723A
  • [36] Clinicopathological Features and Prognosis of B-Cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma with t(14;18) and 8q24 Translocation in the Rituximab Era
    Niitsu, Nozomi
    Takahashi, Naoki
    Kohri, Mika
    Asou, Norio
    Tamaru, Jun-ichi
    Sakai, Jun
    Nakamura, Shigeo
    Miura, Ikuo
    Okamoto, Masataka
    BLOOD, 2014, 124 (21)
  • [37] A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in the Rituximab Era
    Lim, Ryan Mao Heng
    Chan, Natalie Pei Xin
    Khoo, Lay Poh
    Cheng, Chee Leong
    Tan, Leonard
    Yi, Eileen
    Poon, Ling
    Somasundaram, Nagavalli
    Farid, Mohamad
    Tang, Tiffany
    Tao, Miriam
    Lim, Soon Thye
    Chan, Jason Yongsheng
    BLOOD, 2018, 132
  • [38] Clinical features and prognosis of diffuse large B-cell lymphoma with T(14;18) and 8q24 translocations
    Niitsu, N.
    Okamoto, M.
    Miura, I.
    Hirano, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 145 - 145
  • [39] CLINICAL SIGNIFICANCE OF BIOMARKERS OF DIFFUSE LARGE B-CELL LYMPHOMA IN THE RITUXIMAB ERA
    Niitsu, N.
    Hayama, M.
    Hagiwara, Y.
    Tanae, K.
    Kohri, M.
    Takahashi, N.
    ANNALS OF ONCOLOGY, 2011, 22 : 154 - 154
  • [40] Outcomes of cardiac diffuse large B-cell lymphoma (DLBCL) in the rituximab era
    Al-Juhaishi, Taha
    Al-Kindi, Sadeer G.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 339 : 146 - 149
12345